The Committee for Medicinal Products for Human Use recommends marketing approval for Merck's Keytruda for treating two types ...

There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...

Shares of Merck & Co. Inc. MRK shed 1.31% to $115.63 Monday, on what proved to be an all-around great trading session for the ...

Headlines,Wall Street analysts show strong enthusiasm for Merck, (NYSE:MRK),, with the average brokerage recommendation (ABR) ...

Merck & Co Inc (MRK) stock saw a modest uptick, ending the day at $117.96 which represents a slight increase of $2.10 or 1.81% from the prior close of $115.86. The stock opened at $115.8 and touched a ...

Thank you for attending our Global Healthcare Conference. Today, I have the pleasure to host Joe Romanelli, President of Human Health International; and Peter Dannenbaum, Head of Investor Relations.

U.S. stocks were higher after the close on Monday, as gains in the Oil & Gas, Consumer Goods and Basic Materials sectors led ...

U.S. equities were higher at the close on Monday, as gains in the Oil & Gas, Consumer Goods and Basic Materials sectors ...

**NM signifies a non meaningful value. A dash signifies the data is not available.